Pontocerebellar Hypoplasia Type 1 and Associated Neuronopathies
Genes · 15.05.2025 · 16 (5) · 585
DOI: 10.3390/genes16050585 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 15.05.2025. Verfasst von Mario Škarica und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Yale School of Medicine, New Haven, CT 06510, USA. Hauptthemen laut MEDLINE: Olivopontocerebellar Atrophies, Cerebellar Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pontocerebellar hypoplasia is a rare neurodegenerative syndrome characterized by severe hypoplasia or atrophy of pons and cerebellum that may be associated with other brain malformations, microcephaly, optic nerve atrophy, dystonia, ataxia and neuromuscular disorders. At this time, there are 17 variants of PCH distinguished by clinical presentation and distinctive radiological and biochemical features in addition to pontine and cerebellar hypoplasia. PCH1 is defined as PCH variant associated with anterior horn degeneration in the spinal cord with muscle weakness and hypotonia, and is associated with recessive variants in genes VRK1, EXOSC3, EXOSC8, EXOSC9 and SLC25A46. Neuromuscular manifestations may clinically present as amyotrophic lateral sclerosis (ALS), motor neuropathy (HMN) or neuronopathy (non-5q spinal muscular atrophy; SMA) or sensorimotor polyneuropathy (HMSN). Physiologic functions of PCH1-associated genes include regulation of RNA metabolism, mitochondrial fission and neuronal migration. Overall, complex phenotypes associated with PCH1 gene variants ranging from PCH and related neurodevelopmental disorders combined with neuromuscular disorders to isolated neuromuscular disorders have variable outcomes with isolated neuromuscular disorders typically having later onset with better outcomes. Improved understanding of pathogenesis of pontocerebellar hypoplasia and its association with motor neuronopathies and peripheral neuropathies may provide us with valuable insights and lead to potential new therapeutic targets for neurodegenerative disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, Yale School of Medicine, New Haven, CT 06510, USA.
- Division of Neurology, Connecticut Children's Medical Center, St. Hartford, CT 06106, USA.
- Department of Pediatrics, University of Connecticut School of Medicine, Farmington, CT 06030, USA.
- Department of Neurology, University of Connecticut School of Medicine, Farmington, CT 06030, USA.
- Department of Neurology and CMT Program at Yale, Yale School of Medicine, New Haven, CT 06510, USA.
Zitieren
APA
Škarica, M., Acsadi, G., & Živković, S. A. (2025). Pontocerebellar Hypoplasia Type 1 and Associated Neuronopathies. Genes, 16(5), 585. https://doi.org/10.3390/genes16050585
Vancouver
Škarica M, Acsadi G, Živković SA. Pontocerebellar Hypoplasia Type 1 and Associated Neuronopathies. Genes. 2025;16(5):585. doi:10.3390/genes16050585
BibTeX
@article{karica2025,
author = {Škarica, Mario and Acsadi, Gyula and Živković, Sasha A},
title = {Pontocerebellar Hypoplasia Type 1 and Associated Neuronopathies},
journal = {Genes},
year = {2025},
volume = {16},
number = {5},
pages = {585},
doi = {10.3390/genes16050585}
}
EUVIMED